• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGilead

Gilead

HealthU.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
By Lauran Neergaard and The Associated PressJune 19, 2025
HealthA twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’
By Maria Cheng, María Verza and The Associated PressDecember 1, 2024
Brainstorm Health 2021-Gilead-Daniel O'Day
ConferencesGilead’s remdesivir is now used to treat half of hospitalized COVID patients
By Sy MukherjeeApril 28, 2021
A line of syringes shown in silhouette against the AstraZeneca corporate logo.
FinanceAstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth
By Jeremy KahnNovember 6, 2020
Gilead remdesivir price
NewslettersGilead just got the first FDA coronavirus treatment approval, but there are still problems
By Sy MukherjeeOctober 22, 2020
Gilead remdesivir coronavirus FDA
HealthGilead says remdesivir slashes coronavirus deaths. But it’s complicated
By Sy MukherjeeJuly 10, 2020
Brainstorm Health 2020-Eric Lefkofsky
NewslettersCoronavirus exposes the trouble of scientific unknowns
By Sy MukherjeeJuly 10, 2020
Gilead remdesivir coronavirus FDA
HealthCOVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By Sy MukherjeeJune 29, 2020
Gilead coronavirus treatment drug Remdesivir
HealthGilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By Robert Langreth and BloombergJune 29, 2020
Gilead inhaled remdesivir trial
HealthGilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By Sy MukherjeeJune 22, 2020
AstraZeneca Gilead deal
HealthRumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
MagazineWill COVID-19 change how Big Pharma does clinical trials?
By Erika FryMay 15, 2020
HealthAntibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
Gilead remdesivir price
NewslettersGilead’s moral (and financial) COVID-19 conundrum
By Sy MukherjeeMay 7, 2020
Gilead-Sciences-Remdesivir
HealthRemdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.